10.1034/j.1600-065x.2003.00051.x
Crossref journal-article
Wiley
Immunological Reviews (311)
Abstract

Summary:  A properly functioning immune system is dependent on programmed cell death at virtually every stage of lymphocyte development and activity. This review addresses the phenomenon of activation‐induced cell death (AICD) in T lymphocytes, in which activation through the T‐cell receptor results in apoptosis. AICD can occur in a cell‐autonomous manner and is influenced by the nature of the initial T‐cell activation events. It plays essential roles in both central and peripheral deletion events involved in tolerance and homeostasis, although it is likely that different forms of AICD proceed via different mechanisms. For example, while AICD in peripheral T cells is often caused by the induction of expression of the death ligand, Fas ligand (CD95 ligand, FasL), it does not appear to be involved in AICD in thymocytes. This and other mechanisms of AICD are discussed. One emerging model that may complement other forms of AICD involves the inducible expression of FasL by nonlymphoid tissues in response to activated T lymphocytes. Induction of nonlymphoid FasL in this manner may serve as a sensing mechanism for immune cell infiltration, which contributes to peripheral deletion.

Bibliography

Green, D. R., Droin, N., & Pinkoski, M. (2003). Activation‐induced cell death in T cells. Immunological Reviews, 193(1), 70–81. Portico.

Authors 3
  1. Douglas R. Green (first)
  2. Nathalie Droin (additional)
  3. Michael Pinkoski (additional)
References 118 Referenced 497
  1. 10.1016/S1535-6108(02)00024-7
  2. 10.1038/337181a0
  3. 10.1038/339625a0
  4. 10.1126/science.2531464
  5. 10.4049/jimmunol.144.9.3326 / J Immunol / Activation‐induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation by Shi YF (1990)
  6. 10.4049/jimmunol.146.10.3340
  7. 10.1038/349245a0
  8. 10.1038/353858a0
  9. 10.1146/annurev.immunol.17.1.221
  10. 10.1007/BF01978763
  11. 10.1016/0092-8674(92)90123-T
  12. 10.1126/science.1378649
  13. 10.1038/359552a0
  14. 10.1038/359554a0
  15. 10.1038/373441a0
  16. 10.1038/373438a0
  17. 10.1038/373444a0
  18. 10.1084/jem.181.5.1673
  19. 10.4049/jimmunol.152.12.5624
  20. 10.1093/intimm/8.7.1017
  21. 10.1002/eji.1830230951
  22. 10.1006/jaut.1994.1055
  23. 10.1084/jem.181.1.71
  24. 10.1093/intimm/7.9.1451
  25. 10.1084/jem.183.2.431
  26. 10.1128/MCB.19.1.751
  27. 10.1016/S0960-9822(02)01140-5
  28. 10.1523/JNEUROSCI.21-19-07551.2001
  29. 10.1126/science.278.5341.1305
  30. {'key': 'e_1_2_12_31_2', 'first-page': '26', 'article-title': 'Nonlymphoid Fas ligand in peptide‐induced peripheral lymphocyte deletion', 'volume': '26', 'author': 'Pinkoski MJ', 'year': '2002', 'journal-title': 'Proc Natl Acad Sci USA'} / Proc Natl Acad Sci USA / Nonlymphoid Fas ligand in peptide‐induced peripheral lymphocyte deletion by Pinkoski MJ (2002)
  31. 10.1038/82725
  32. 10.4049/jimmunol.162.1.263 / J Immunol / Fas/Fas ligand‐driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis by Stassi G (1999)
  33. 10.1038/6509
  34. 10.1016/S1097-2765(00)80054-4
  35. 10.1038/nm0596-574
  36. 10.1038/sj.cdd.4400419
  37. 10.1073/pnas.94.15.8144
  38. 10.1126/science.285.5429.898
  39. 10.1038/35036608
  40. WanYY DeGregoriJ.The survival of antigen stimulated T cells requires NFκB mediated inhibition of p73 expression.Immunity2003;18:331–342. (10.1016/S1074-7613(03)00053-0)
  41. 10.1084/jem.188.11.2033
  42. 10.1016/1074-7613(94)90067-1
  43. 10.4049/jimmunol.147.2.466 / J Immunol / Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice by Zhou T (1991)
  44. 10.1016/S1074-7613(00)80549-X
  45. 10.1093/emboj/17.3.706
  46. 10.1038/ni894
  47. 10.1016/S1074-7613(00)80401-X
  48. 10.1038/ni0303-207
  49. 10.1038/415922a
  50. 10.1038/sj.cdd.4400329
  51. 10.1016/0092-8674(91)90361-2
  52. 10.1073/pnas.89.15.7003
  53. 10.1016/0092-8674(91)90362-3
  54. 10.1002/eji.1830261235
  55. 10.1016/S1074-7613(00)80306-4
  56. 10.1038/377348a0
  57. 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X
  58. 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3
  59. 10.1016/S1074-7613(02)00322-9
  60. 10.1084/jem.20020827
  61. 10.1126/science.286.5445.1735
  62. 10.4049/jimmunol.159.10.4737 / J Immunol / Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma‐chain: defective Fas ligand expression in gamma‐chain‐deficient mice by Nakajima H (1997)
  63. 10.1016/S1074-7613(00)80668-8
  64. 10.1038/35103104
  65. 10.1126/science.270.5239.1189
  66. 10.4049/jimmunol.169.9.4739
  67. 10.1126/science.274.5291.1363
  68. 10.1016/S0167-5699(98)01382-6
  69. 10.1073/pnas.94.8.3943
  70. 10.1038/nm0797-738
  71. 10.4049/jimmunol.162.1.518 / J Immunol / Accelerated rejection of Fas ligand‐expressing heart grafts by Takeuchi T (1999)
  72. 10.1172/JCI119173
  73. 10.1182/blood.V99.8.2940
  74. 10.1084/jem.191.7.1209
  75. 10.1016/1074-7613(94)90084-1
  76. 10.1038/35065111
  77. 10.1146/annurev.immunol.19.1.23
  78. 10.1074/jbc.M208167200
  79. 10.1016/S1074-7613(94)80016-2
  80. 10.1034/j.1600-0528.2002.017412.x
  81. {'key': 'e_1_2_12_82_2', 'first-page': '184', 'article-title': 'Fas ligand‐deficient gld mice are more susceptible to graft‐versus‐host‐disease', 'volume': '70', 'author': 'Van Den Brink MR', 'year': '2000', 'journal-title': 'Transplantation'} / Transplantation / Fas ligand‐deficient gld mice are more susceptible to graft‐versus‐host‐disease by Van Den Brink MR (2000)
  82. 10.1172/JCI8236
  83. 10.1084/jem.189.8.1195
  84. 10.1016/S0962-8924(97)01215-4
  85. 10.1126/science.281.5383.1680
  86. 10.1126/science.289.5488.2350
  87. 10.1126/science.281.5379.998
  88. 10.1128/MCB.19.9.5923
  89. 10.1074/jbc.274.3.1541
  90. 10.1016/S1074-7613(00)80566-X
  91. 10.1084/jem.180.6.2413
  92. 10.1074/jbc.275.13.9767
  93. 10.1016/S0960-9822(00)00727-2
  94. 10.1084/jem.189.2.231
  95. 10.1046/j.1365-2613.1999.00106.x
  96. 10.1016/S1074-7613(00)80660-3
  97. 10.4049/jimmunol.158.10.4602 / J Immunol / Regulation of CD95 (Fas) ligand expression by TCR‐mediated signaling events by Latinis KM (1997)
  98. 10.1093/emboj/19.17.4783
  99. 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.0.CO;2-B
  100. 10.1074/jbc.272.50.31427
  101. 10.4049/jimmunol.161.3.1078 / J Immunol / A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes by Norian LA (1998)
  102. 10.1074/jbc.274.12.7756
  103. 10.1128/MCB.18.7.3744
  104. 10.1074/jbc.274.5.3222
  105. 10.1016/S1074-7613(00)80182-X
  106. 10.1093/intimm/6.10.1545
  107. 10.1084/jem.185.10.1837
  108. 10.1016/S0166-2236(98)01343-5
  109. 10.1146/annurev.immunol.16.1.225
  110. 10.1016/S0092-8674(02)00703-1
  111. 10.1074/jbc.274.2.987
  112. 10.1038/sj.cdd.4400611
  113. 10.4049/jimmunol.160.1.134
  114. 10.1084/jem.190.2.253
  115. 10.1074/jbc.275.14.10023
  116. 10.1016/S0092-8674(00)80595-4
  117. 10.1128/MCB.22.2.680-691.2002
  118. 10.4049/jimmunol.166.2.1028
Dates
Type When
Created 22 years, 3 months ago (May 12, 2003, 11:23 a.m.)
Deposited 1 year, 10 months ago (Oct. 13, 2023, 7:44 p.m.)
Indexed 1 week, 1 day ago (Aug. 22, 2025, 12:45 a.m.)
Issued 22 years, 3 months ago (May 12, 2003)
Published 22 years, 3 months ago (May 12, 2003)
Published Online 22 years, 3 months ago (May 12, 2003)
Published Print 22 years, 2 months ago (June 1, 2003)
Funders 0

None

@article{Green_2003, title={Activation‐induced cell death in T cells}, volume={193}, ISSN={1600-065X}, url={http://dx.doi.org/10.1034/j.1600-065x.2003.00051.x}, DOI={10.1034/j.1600-065x.2003.00051.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Green, Douglas R. and Droin, Nathalie and Pinkoski, Michael}, year={2003}, month=may, pages={70–81} }